Enabling Protein Degradation Drug Discovery

Home » News & Events » Archives for Featured

Ubiquigent celebrates milestone anniversary of DUBprofiler™ compound profiling platform

Posted on December 14th, 2021 in News
Dundee, UK, 14th December 2021: Today, Ubiquigent Limited (Ubiquigent) celebrates the 10th anniversary of its DUBprofiler™ compound profiling platform together with KSQ Therapeutics joining its expanding customer base. Over the last 10 years Ubiquigent has profiled thousands of compounds across… Read more

Ubiquigent Extends and Expands Drug Discovery Collaboration with Bristol Myers Squibb

Posted on October 26th, 2021 in News
Dundee, UK, 26th October 2021: Ubiquigent Limited (Ubiquigent) today announces the extension and expansion of its long-term collaboration with Bristol Myers Squibb.  Under the terms of the agreement, Ubiquigent will provide Bristol Myers Squibb with increased access to its deubiquitylase… Read more

Medivir licenses USP7 program to Ubiquigent

Posted on February 10th, 2021 in News
Dundee, UK 10th February 2021 — Ubiquigent Limited (Ubiquigent) announced today that it has entered into a license agreement with Medivir AB (Nasdaq Stockholm: MVIR) for Medivir’s preclinical USP7 research program. Under the terms of the agreement, Medivir has granted… Read more